A drug may cause problems with chemotherapies in cancer patients with obesity

Taking stock of the drug industry, from the lab to the medicine chest

October 28, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | A drug may cause problems with chemotherapies in cancer patients with obesity. Many doctors are in the dark Many doctors are in the dark about certain effects of posaconazole because the label doesn't reflect them. Merck says any issues are well-described already. By Ed Silverman STAT+ | Charles River shipments of research monkeys to Canada spark a probe The flights have also prompted a probe by officials who oversee an international treaty governing endangered species. By Ed Silverman STAT+ | Helsinki Declaration says researchers must disclose trial results on a timely basis The revision comes after ongoing controversy surrounding the disclosure of clinical trial work and lobbying to push for greater oversight. By Ed Silverman Yale Rosen/ Wikimedia Commons STAT+ | Novartis, Seagen veteran David Epstein is back, leading a new cancer startup The biotech, Ottimo Pharma, is developing an antibody targeting two key proteins, an approach a number of companies are pursuing. By Andrew Joseph

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser